×
About 1,758 results

ALLMedicine™ Gastrointestinal Hemorrhage Center

Research & Reviews  449 results

An Unusual Case of Lower Gastrointestinal Hemorrhage.
https://doi.org/10.1053/j.gastro.2023.02.039
Gastroenterology Xiong S, Lin S et. al.

Mar 9th, 2023 - An Unusual Case of Lower Gastrointestinal Hemorrhage.|2023|Xiong S,Lin S,Mao R,|

Acute Fatty Liver of Pregnancy
http://emedicine.medscape.com/article/1562425-overview

Mar 9th, 2023 - Practice Essentials Acute fatty liver of pregnancy (AFLP) is a serious complication unique to pregnancy first described by Sheehan in 1940. [1] It is characterized by microvesicular steatosis in the liver. The foremost cause of AFLP is thought to ...

Acute Fatty Liver of Pregnancy
https://emedicine.medscape.com/article/1562425-print

Mar 9th, 2023 - Practice Essentials Acute fatty liver of pregnancy (AFLP) is a serious complication unique to pregnancy first described by Sheehan in 1940.[1] It is characterized by microvesicular steatosis in the liver. The foremost cause of AFLP is thought to b...

Acute Fatty Liver of Pregnancy
https://emedicine.medscape.com/article/1562425-overview

Mar 9th, 2023 - Practice Essentials Acute fatty liver of pregnancy (AFLP) is a serious complication unique to pregnancy first described by Sheehan in 1940. [1] It is characterized by microvesicular steatosis in the liver. The foremost cause of AFLP is thought to ...

Acute Fatty Liver of Pregnancy Clinical Presentation
https://emedicine.medscape.com/article/1562425-clinical

Mar 9th, 2023 - History Clinical presentation of acute fatty liver of pregnancy (AFLP) is nonspecific, and the patient can present with the following complaints: Malaise Nausea and vomiting (70%); this may present for the first time in the third trimester Right u...

see more →

Guidelines  1 results

Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Soc...
https://doi.org/10.1055/s-0034-1393172
Endoscopy Gralnek IM, Dumonceau JM et. al.

Sep 30th, 2015 - This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH). Main Recommendations MR1. ESGE recommends im...

see more →

Drugs  92 results see all →

Clinicaltrials.gov  46 results

Bilirubin Increases the Risk of Nosocomial Infection in Cirrhotic Patients
https://clinicaltrials.gov/ct2/show/NCT05752084

Mar 6th, 2023 - Cirrhosis is the 14th most widespread cause of mortality worldwide [1], cirrhosis can take one of the following forms: compensated and decompensated phases [2]. The latter is related to subsequent complications such as ascites, hepatic encephalopa...

Prophylactic Antibiotics in Admitted Cirrhotics
https://clinicaltrials.gov/ct2/show/NCT04218695

Mar 3rd, 2023 - Cirrhosis is associated with a state of immune-compromise and progressive decompensation, acute on chronic liver failure (ACLF), and death are often caused by bacterial infections. Different sub-groups of patients with cirrhosis at increased risk,...

Stress Hydrocortisone In Pediatric Septic Shock
https://clinicaltrials.gov/ct2/show/NCT03401398

Feb 6th, 2023 - Sepsis represents the most common cause of childhood mortality worldwide. In the United States alone, 200 cases of pediatric sepsis are diagnosed each day, with an associated hospital mortality rate of 5-10% and health care expenditures now approa...

Clinical Investigation of Safety and Performance of a Medical Device (ClearPlasma) for the Treatment of Patients With Acute Upper Gastrointestinal Hemorrhage.
https://clinicaltrials.gov/ct2/show/NCT04174989

Nov 15th, 2022 - Upper gastrointestinal hemorrhage (UGIH) is one of the most common gastrointestinal emergencies, and is associated with significant morbidity and mortality. Acute upper gastrointestinal hemorrhage (AUGIH) management guidelines call for aggressive ...

Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver Cirrhosis
https://clinicaltrials.gov/ct2/show/NCT04711122

Oct 28th, 2022 - cute variceal bleeding is one of the major causes of death in cirrhotic patients . It is also the major cause of upper gastrointestinal (GI) bleeding in cirrhotic patients, accounting for 70% of cases . Mortality during the first episode is estima...

see more →

News  115 results

Emavusertib Is Active in Heavily Pretreated AML and High-Risk MDS With Targeted Mutations
https://www.onclive.com/view/emavusertib-is-active-in-heavily-pretreated-aml-and-high-risk-mds-with-targeted-mutations

Oct 24th, 2022 - Emavusertib (CA-4948) elicited antitumor activity when given as a monotherapy in patients with relapsed/refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS) that harbored a spliceosome or FLT3 mutation, according ...

Frontline Aumolertinib Significantly Improves PFS Over Gefitinib in EGFR-Mutated NSCLC
https://www.onclive.com/view/frontline-aumolertinib-significantly-improves-pfs-over-gefitinib-in-egfr-mutated-nsclc

Sep 29th, 2022 - Aumolertinib significantly prolonged progression-free survival (PFS) vs gefitinib (Iressa) in treatment-naïve patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring EGFR mutations, according to findings from the ...

Race, Insurance Status Linked to Poor Outcomes in Hospitalized UC Patients
https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/100023

Aug 2nd, 2022 - Race/ethnicity and insurance status were associated with poor outcomes among hospitalized patients with ulcerative colitis (UC), according to a nationally representative cohort study. Among nearly 35,000 people included in the cohort, Black patien...

Falsified IBS Data; Patients' Top Choice for CRC Screening; Fertility and IBD Drugs
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/99833

Jul 21st, 2022 - Two women from Florida pleaded guilty in connection to a conspiracy to falsify data for clinical trials evaluating therapies for irritable bowel syndrome (IBS), among other conditions, the Department of Justice announced. Doctors Without Borders a...

Novel Antifibrotic Improved Fibrosis in Chronic Hepatitis B
https://www.medpagetoday.com/gastroenterology/generalhepatology/99748

Jul 15th, 2022 - Investigational hydronidone, when added to entecavir (Baraclude), reduced liver fibrosis for chronic hepatitis B patients, a phase II trial in China found. In an intention-to-treat analysis of 168 such patients, the direct-acting antifibrotic agen...

see more →